.png "Tenet Healthcare (NYSE: THC)")
In a report released today, Ralph Giacobbe from Citigroup maintained a Buy rating on Tenet Healthcare (THC), with a price target of $37. The company’s shares closed yesterday at $26.94.
According to TipRanks.com, Giacobbe is a 4-star analyst with an average return of 11.8% and a 66.0% success rate. Giacobbe covers the Services sector, focusing on stocks such as Quest Diagnostics Inc, Cigna Corp, and Humana Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $30.29 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $39.74 and a one-year low of $16.61. Currently, Tenet Healthcare has an average volume of 1.46M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
